The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer
Abstract
MicroRNAs are small, non-coding RNAs that influence gene regulatory networks by post-transcriptional regulation of specific messenger RNA targets. MicroRNA expression is dysregulated in human malignancies, frequently leading to loss of expression of certain microRNAs. We report that expression of hsa-miR-342, a microRNA encoded in an intron of the gene EVL, is commonly suppressed in human colorectal cancer. The expression of hsa-miR-342 is coordinated with that of EVL and our results indicate that the mechanism of silencing is CpG island methylation upstream of EVL. We found methylation at the EVL/hsa-miR-342 locus in 86% of colorectal adenocarcinomas and in 67% of adenomas, indicating that it is an early event in colorectal carcinogenesis. In addition, we observed a higher frequency of methylation (56%) in histologically normal colorectal mucosa from individuals with concurrent cancer compared to mucosa from individuals without colorectal cancer (12%), suggesting the existence of a 'field defect' involving methylated EVL/hsa-miR-342. Furthermore, reconstitution of hsa-miR-342 in the colorectal cancer cell line HT-29 induced apoptosis, suggesting that this microRNA could function as a proapoptotic tumor suppressor. In aggregate, these results support a novel mechanism for silencing intronic microRNAs in cancer by epigenetic alterations of cognate host genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MiR-342 is encoded in the third intron of the Evl gene (Enah/Vasp-like, NM_016337) 39 and we identified a PU.1-binding site 40 near the promoter region of the host gene (at 5 kb upstream of the transcription start site), which was increasingly occupied by PU.1 during PUER differentiation and was marked by a DNase HSS in mature macrophages.”
From Macrophage development from HSCs requires PU.1-coordinated microRNA expression (2011) · cites this paper as [39]
Citations
Cites
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Flagged first, then by citations
Research works printed but not linked: 27
- Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D et al. (1999). Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745–6750. · DOI
- Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N et al. (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29. · DOI
- Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297. · DOI
- Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M et al. (2007). The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419–1423. · DOI
- Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz Jr LA, Sjoblom T et al. (2006). The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687–3692. · DOI · Paper page
- Grady WM, Rajput A, Lutterbaugh J, Markowitz S . (2001). Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 61: 900–902.
- Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (Database issue): D140–D144. · DOI · Paper page
- He L, Hannon GJ . (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522–531. · DOI · Paper page
- Kim YK, Kim VN . (2007). Processing of intronic microRNAs. EMBO J 26: 775–783. · DOI · Paper page
- Kim YH, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S et al. (2006). CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45: 781–789. · DOI
- Kondo Y, Issa JP . (2004). Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 23: 29–39. · DOI
- Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB . (2003). Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19: 541–564. · DOI
- Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20. · DOI · Paper page
- Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424–1429. · DOI
- Michael MZ, O’Connor SM, van Holst Pellekaan NG, Young GP, James RJ . (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882–891.
- Myohanen S, Baylin S, Herman J . (1998). Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58: 591–593.
- Notterman DA, Alon U, Sierk AJ, Levine AJ . (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124–3130.
- Ohm JE, Baylin SB . (2007). Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 6: 1040–1043. · DOI
- Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB et al. (2007). Oncomine 3.0: genes, pathways, and networks in a collection of 18 000 cancer gene expression profiles. Neoplasia 9: 166–180. · DOI
- Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A . (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res 14 (10A): 1902–1910. · DOI · Paper page
- Saini HK, Griffiths-Jones S, Enright AJ . (2007). Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA 104: 17719–17724. · DOI
- Saito Y, Jones PA . (2006). Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 5: 2220–2222. · DOI
- Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M et al. (1999). Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307–2312.
- Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257–2261. · DOI · Paper page
- Wijnhoven BP, Michael MZ, Watson DI . (2007). MicroRNAs and cancer. Br J Surg 94: 23–30. · DOI
- Zhang B, Pan X, Cobb GP, Anderson TA . (2007). MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1–12. · DOI
- Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y et al. (2002). Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21: 4855–4862. · DOI
Cited by
Sorted by citations
Macrophage development from HSCs requires PU.1-coordinated microRNA expression
Ghani, S., Riemke, P., Schönheit, J., Lenze, D., Stumm, J., Hoogenkamp, M., Lagendijk, A., Heinz, S., Bonifer, C., Bakkers, J., et al. (2011) · Blood · doi:10.1182/blood-2011-02-335141 · Cited by 123
Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network
Li, J.-L., Mazar, J., Zhong, C., Faulkner, G. J., Govindarajan, S. S., Zhang, Z., Dinger, M. E., Meredith, G., Adams, C., Zhang, S., et al. (2013) · Scientific Reports · doi:10.1038/srep02962 · Cited by 21
Metadata
- Authors
- Grady, W. M., Parkin, R. K., Mitchell, P. S., Lee, J. H., Kim, Y.-H., Tsuchiya, K. D., Washington, M. K., Paraskeva, C., Willson, J. K. V., Kaz, A. M., Kroh, E. M., Allen, A., Fritz, B. R., Markowitz, S. D., & Tewari, M.
- Venue
- Oncogene
- Published
- 2008-02-11
- Volume
- 27
- Issue
- 27
- Pages
- 3880-3888
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 245
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review